a public good project by the
Synthesis
Company
of California

© 2026

Lin‐Kun An | doi.page

0 works0 citations0 h-index

Lin‐Kun An

Sun Yat-sen University(CN)Key Laboratory of Guangdong Province(CN)

Publications by Year

Research Areas

Cancer therapeutics and mechanisms, Bioactive Compounds and Antitumor Agents, Synthesis and Biological Evaluation, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography

Most-Cited Works

→ Turning off Transcription of the bcl-2 Gene by Stabilizing the bcl-2 Promoter Quadruplex with Quindoline Derivatives(2010)124 cited
→ Meroterpenoids with Antitumor Activities from Guava (Psidium guajava)(2017)109 cited
→ Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors(2008)64 cited
→ Synthesis, cytotoxic activities and structure–activity relationships of topoisomerase I inhibitors: Indolizinoquinoline-5,12-dione derivatives(2008)60 cited
→ A Novel DNA Topoisomerase I Inhibitor with Different Mechanism from Camptothecin Induces G2/M Phase Cell Cycle Arrest to K562 Cells(2010)59 cited
→ Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors(2010)58 cited

→ The metabolites of mangrove endophytic fungus Zh6-B1 from the South China Sea(2010)

51 cited

→ Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents(2018)50 cited

→ Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities(2010)46 cited

→ Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II(2013)44 cited